This event brings together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia to explore business opportunities with Taiwan’s emerging biotech sector.

Presentation by Bachem

Innovation that transforms lives –
oligonucleotide manufacturing at Bachem

by Naoki Yamamoto, Head of BD & Sales Asia Pacific at Bachem Japan

Bachem is a leading contract development and manufacturing organization (CDMO) focused on the manufacturing of peptide and oligonucleotide drug substances. The therapeutic usage of oligonucleotide-based drugs is increasing, with indications expanding from orphan to chronic diseases. We are currently investing in new facilities and innovative technologies to satisfy the unmet needs around capacity in the market, in order to support our customers in their projects and to contribute to medicines, helping patients worldwide. Our presentation will guide you through the capabilities and latest technological developments we have in place for the manufacturing of oligonucleotides.

Available on demand starting July 25, 2022